MENU
+Compare
CRDL
Stock ticker: NASDAQ
AS OF
Sep 15 closing price
Price
$1.08
Change
+$0.01 (+0.93%)
Capitalization
90.03M

CRDL Cardiol Therapeutics Forecast, Technical & Fundamental Analysis

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases... Show more

CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CRDL with price predictions
Sep 15, 2025

CRDL sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for CRDL moved below the 200-day moving average on September 15, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRDL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CRDL's RSI Oscillator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where CRDL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 15, 2025. You may want to consider a long position or call options on CRDL as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CRDL just turned positive on September 11, 2025. Looking at past instances where CRDL's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRDL advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

CRDL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.515) is normal, around the industry mean (17.216). P/E Ratio (0.000) is within average values for comparable stocks, (74.405). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). CRDL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.000) is also within normal values, averaging (46.810).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CRDL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRDL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRDL is expected to report earnings to rise 23.27% to -8 cents per share on November 18

Cardiol Therapeutics CRDL Stock Earnings Reports
Q3'25
Est.
$-0.09
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.05
The last earnings report on August 19 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 394.86K shares outstanding, the current market capitalization sits at 90.03M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
2265 Upper Middle Road East
Phone
+1 289 910-0850
Employees
22
Web
https://www.cardiolrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESVIF1.720.11
+6.83%
Ensign Energy Services Inc.
SGGEF14.810.37
+2.57%
Sage Group plc (The)
ATRRF115.13N/A
N/A
Altarea Paris
CPROF1.21N/A
N/A
Cortelco Systems Puerto Rico Inc.
HYLQF1.70-0.11
-6.08%
HYLQ STRATEGY CORP.

CRDL and Stocks

Correlation & Price change

A.I.dvisor tells us that CRDL and ACB have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
+0.93%
ACB - CRDL
31%
Poorly correlated
+2.05%
OGI - CRDL
28%
Poorly correlated
+3.01%
EOLS - CRDL
28%
Poorly correlated
-7.79%
LNTH - CRDL
27%
Poorly correlated
-2.27%
SCYX - CRDL
24%
Poorly correlated
-1.79%
More

Groups containing CRDL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
+0.93%
Pharmaceuticals: Generic
industry (221 stocks)
7%
Poorly correlated
+27.01%